Xellia Pharmaceuticals Receives US FDA Approval for Premixed Vancomycin Injection

Xellia Pharmaceuticals , a global leader in the manufacturing of specialty anti-infective treatments, announced it has received U.S. FDA approval for Premixed Vancomycin Injection in a Ready-to-Use bag in the United States market.

Glatt launches phosphorus recovery system and compact fluidised bed agglomeration solution

At POWTECH 2019 in Nuremberg, plant manufacturing and process development specialist, Glatt, is presenting a groundbreaking waste-free process that recycles...

Jubilant Biosys Expands Collaboration with Sanofi in CNS Therapeutic Area

Jubilant Biosys announced a new integrated drug discovery collaboration with Sanofi in the CNS therapeutic area. The first collaboration with Sanofi started in 2016, to discover and develop..

West and Swissfillon to Partner on an Integrated Solution for Clinical Filling of SmartDose Drug Delivery Platform

West is pleased to announce that it has commenced discussions with Swissfillon AG, a provider of aseptic fill and finish services to pharmaceutical and biotechnology companies.

NFC-Label by Schreiner MediPharm for Ypsomed's SmartPilot Supports Smart Self-Medication

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, in cooperation with Ypsomed...

Ochsner Health System and Pfizer Partner to Develop Innovative Models for Clinical Trials

Ochsner Health System and Pfizer Inc have entered into a multi-year strategic alliance to develop innovative models for clinical trials. Pfizer and Ochsner through...

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack / Editorial Calendar please click here

For the latest visit: www.worldpharmatoday.com